Research suggests gut bacteria enhance vegetable benefits for blood pressure and vascular function — Evidence Review
Published in Cell, by researchers from Karolinska Institutet, University Medical Centre Hamburg-Eppendorf, Johannes Gutenberg University Medical Centre Mainz
Researched by
— the AI search engine for science
Table of Contents
Researchers at Karolinska Institutet have discovered that gut microbes can convert dietary nitrate and iron into dinitrosyl iron complexes (DNICs), which may help protect against cardiovascular and metabolic disease. Related studies generally support the finding that plant-based diets and their influence on the gut microbiome are linked to improved cardiovascular health (1, 4, 9).
- Multiple studies demonstrate that plant-based diets alter gut microbiota composition, increasing beneficial metabolites and reducing cardiovascular risk factors, which aligns with the mechanism proposed in the new research (1, 3, 4, 5).
- Prior research has found that dinitrosyl iron complexes can lower blood pressure in animal and human studies, providing experimental support for the potential effects observed in the current study (6).
- While most previous work focused on metabolites like short-chain fatty acids and trimethylamine N-oxide, the identification of DNICs as a new microbiota-derived molecule adds to the growing body of evidence connecting gut bacteria, diet, and systemic health outcomes (8, 9, 10).
Study Overview and Key Findings
Understanding how dietary components interact with gut microbiota to affect systemic health is a rapidly advancing area of research. This study, conducted at Karolinska Institutet alongside German collaborators, investigates a novel pathway by which gut bacteria transform dietary nitrate and non-haem iron into dinitrosyl iron complexes (DNICs), with potential protective effects against cardiovascular and metabolic diseases. The research combines animal, cellular, bacterial, and human sample experiments to elucidate the biochemical and physiological roles of these newly identified molecules, with implications for dietary guidance and disease prevention strategies.
| Property | Value |
|---|---|
| Organization | Karolinska Institutet, University Medical Centre Hamburg-Eppendorf, Johannes Gutenberg University Medical Centre Mainz |
| Journal Name | Cell |
| Authors | Andrei L. Kleschyov, Mattias Carlström, Jon Lundberg |
| Population | Mice, cells, bacteria, human samples |
| Methods | Animal Study |
| Outcome | DNIC levels, blood pressure, vascular function, blood sugar control, liver fat |
| Results | Higher DNIC levels improved blood pressure and vascular function. |
Literature Review: Related Studies
To contextualize these findings, we searched the Consensus paper database—covering over 200 million research papers—using targeted queries for evidence on gut bacteria, vegetable consumption, DNICs, and vascular health. The following search queries guided our review:
- gut bacteria vegetable benefits
- DNIC levels blood pressure improvement
- vascular function gut microbiome relationship
Key Topics and Findings from Related Studies
| Topic | Key Findings |
|---|---|
| How do plant-based diets and specific vegetables affect gut microbiota and cardiovascular health? | - Plant-based diets increase beneficial gut bacteria and microbial metabolites (short-chain fatty acids), which are linked to reduced cardiovascular risk (1, 4, 5). - Consumption of specific vegetables, such as broccoli, alters gut microbiota composition, increasing Bacteroidetes and beneficial metabolic pathways (2). |
| What is the evidence that specific microbial metabolites, including DNICs, impact blood pressure and vascular function? | - DNICs have been shown to lower blood pressure in animals and healthy volunteers, with minimal side effects (6). - Other gut microbe-derived metabolites, such as short-chain fatty acids and TMAO, have been linked to cardiovascular health, with some promoting and others reducing disease risk (8, 9, 10). |
| How does the gut microbiome influence the risk of cardiovascular and metabolic diseases? | - Altered gut microbiota composition is associated with hypertension, atherosclerosis, and metabolic disease, with evidence for both causative and associative roles (7, 8, 9, 10, 11). - Plant-based and high-fiber diets shift microbiota in ways thought to reduce inflammation and improve metabolic profiles (1, 4, 5, 3). |
How do plant-based diets and specific vegetables affect gut microbiota and cardiovascular health?
Multiple studies have demonstrated that plant-based diets promote a diverse and beneficial gut microbiome, which is associated with improved cardiovascular health outcomes. The current study adds to this body of evidence by suggesting a specific microbial pathway—production of DNICs from dietary nitrate and iron—that may explain part of the protective effect of vegetable-rich diets.
- Plant-based diets increase the abundance of beneficial bacteria such as Bacteroidetes and lactic acid bacteria, which are linked to improved metabolic and cardiovascular markers (1, 2, 4, 5).
- Broccoli and other vegetables can alter the composition and function of the microbiome, increasing pathways involved in energy metabolism and reducing potentially pathogenic species (2).
- Increased intake of fruits and vegetables correlates with reduced risk factors for cardiovascular disease, partly through modulation of gut bacteria and their metabolites (3, 4).
- The new findings on DNICs provide an additional mechanistic layer for how plant-based diets confer cardiovascular protection, aligning with previous evidence on microbiota-mediated health benefits (1, 2, 4).
What is the evidence that specific microbial metabolites, including DNICs, impact blood pressure and vascular function?
While most research to date has focused on short-chain fatty acids and TMAO as key microbial metabolites influencing cardiovascular health, there is emerging evidence that DNICs may also play a significant role. The new study demonstrates that increasing DNIC levels improves cardiovascular markers in animal models, complementing earlier experimental and early clinical findings.
- DNICs with glutathione, administered as the compound Oxacom®, have been found to lower blood pressure in animal models and healthy volunteers, supporting their potential as hypotensive agents (6).
- Other microbial metabolites, such as short-chain fatty acids, are well-established in their ability to lower blood pressure and improve vascular function, but some (like TMAO) may increase risk (8, 9, 10).
- The new research broadens the array of microbiota-derived molecules with systemic effects, highlighting the diversity of gut-derived compounds that can modulate host physiology (6, 8, 9).
- This study’s findings provide a novel mechanistic explanation for the blood pressure-lowering effects of vegetable-rich diets, mediated by gut microbiota (6, 1, 4).
How does the gut microbiome influence the risk of cardiovascular and metabolic diseases?
The relationship between the gut microbiome and cardiometabolic health is increasingly recognized as complex and multifactorial. Changes in gut microbial composition and function have been linked to both the development and prevention of cardiovascular and metabolic diseases.
- Dysbiosis, or imbalance in gut microbiota, is associated with hypertension, atherosclerosis, and metabolic diseases, often through inflammatory pathways and altered metabolite production (7, 8, 9, 10, 11).
- Plant-based and high-fiber diets are generally associated with favorable microbiota profiles and reduced inflammation, which may lower disease risk (1, 4, 5, 3).
- Experimental models show that transplantation or modulation of the gut microbiota can directly influence disease phenotypes, suggesting a causal role (9, 11).
- The identification of DNICs as microbiota-derived molecules adds another potential link in the chain from dietary habits, through microbial metabolism, to host health outcomes (6, 9, 10).
Future Research Questions
While the current study presents novel insights, further work is needed to clarify the relevance of DNICs in human health, optimize their measurement, and explore their therapeutic potential. Important gaps remain regarding the translation of findings from animal models to humans and the broader implications for dietary recommendations and microbiome-targeted interventions.
| Research Question | Relevance |
|---|---|
| How do DNIC levels in humans correlate with cardiovascular and metabolic health? | Determining whether DNICs measured in human tissues or blood are associated with disease risk or health outcomes is critical for translating animal findings to clinical practice (6, 9). |
| Which specific gut bacteria are responsible for DNIC production in humans? | Identifying bacterial species with the capacity to generate DNICs will enable targeted dietary or probiotic interventions and deepen our understanding of host-microbe interactions (1, 2, 4). |
| Can modifying diet or microbiota composition increase DNIC levels and improve health in humans? | Interventions to enhance DNIC production could have therapeutic potential if shown to be effective and safe in humans, expanding on existing strategies using diet or probiotics to promote beneficial metabolites (1, 4, 5, 6). |
| What are the mechanisms by which DNICs exert cardiovascular and metabolic effects in humans? | Understanding the cellular and molecular pathways affected by DNICs will inform both drug development and dietary guidelines for disease prevention (6, 8, 9). |
| Are there other microbial metabolites with similar protective effects yet to be identified? | Exploring the full spectrum of gut microbiota-derived molecules could reveal additional targets for preventing or treating cardiovascular and metabolic diseases (8, 9, 10). |
This article presents a comprehensive synthesis of current evidence linking dietary components, gut microbiota, and cardiovascular-metabolic health, highlighting emerging mechanistic pathways such as DNIC formation. Future research addressing the outlined questions will be essential for translating these findings into effective interventions.